Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Atripla

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Atripla was produced by Gilead Sciences.

OPEN Health acquires Lane Earl Cox

LEC was established in 1993 and has worked on brands including Lipitor, Losec, Vioxx, Aricept, Symbicort, Atripla and Prozac.

Gilead files HIV combo drug with FDA

The first, Atripla, was approved by the FDA in 2006 and is marketed by Bristol-Myers Squibb and Gilead.

A competitive edge

Interim results from a phase II trial comparing Quad with efavirenz/emtricitabine/tenofovir disoproxil fumarate (Atripla; Gilead, Bristol-Myers Squibb) in treatment-naïve HIV-infected patients were presented at the 17th ... CROI. These results

One-a-day HIV pill recommended for EU approval

Atripla, the first one-a-day combination HIV pill, is recommended for approval in the EU, according to Gilead Sciences. ... A final decision on Atripla by the EU Commission is expected by the end of 2007.

Pharma news in brief

The application for the drug, Atripla, will be reviewed by the Committee for Medicinal Products for Human Use (CHMP). ... Atripla is a once-daily single tablet regimen approved in the US for the treatment of HIV-1 infection in adults for use either as a

[ Previous 5 results ] 1 2 3 4 5 6 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
IGNIFI

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

Has the pandemic opened up a future of accelerated diagnosis and better care for rare disease patients?
The challenge with rare disease is in the name – it's rare, so awareness is limited and diagnosis hindered. Could a more virtual existence change this? A Medical Affairs viewpoint...
The other side of … blood cancer
To stay motivated for the fight, some patients need to feel like active players in the treatment journey, not passengers to every decision....
COVID clinical trial
COVID-19 – a catalyst for technology adoption in clinical trials
As the COVID-19 crisis disrupts clinical trials around the globe, it is also proving to be a catalyst that may transform its approach to trials for good...

Infographics